Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy Major peptide regulatory news this week. The FDA announced on April 15 that it will remove 12 peptides from Category 2 of the 503A bulk drug substances list after seven calendar days. BREAKING: FDA UPDATES CATEGORY 2 BULKS LIST OFFICIALLY REMOVES PEPTIDES LIKE BPC 157 The first opportunity for reclassification comes on July 23 24 during the FDA's PCAC meeting Until then, peptides are FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure FDA Removes 12 Peptides from 503A Category 2 Newtropin BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 (compounding only, no legal prescribing) into Category 1. This means